Back to search
FDAFDA · Food and drugs·Recall number D-0331-2021

Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14.

Published April 21, 2021 · Recall initiated: March 29, 2021

Summary

FDA records drug Class III recall D-0331-2021, published April 21, 2021 and initiated March 29, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: 62,040 tubes; Lot: Lot 13269, Exp March 2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: product did not meet viscosity results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teligent Pharma, Inc.
Distributor
Nationwide in the USA
Lot
Lot 13269, Exp March 2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14. recalled?

Yes. FDA published recall D-0331-2021 on April 21, 2021. Reported hazard: Failed Stability Specifications: product did not meet viscosity results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter